GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Scientists from Monash University have designed a nano-sized "Trojan horse" particle to ensure that healing antioxidants and therapeutic drugs can be better absorbed by the human body. The nanoparticle, one thousandth the thickness of a human hair, protects antioxidants from being destroyed in the gut and ensures a better chance of them being taken up in the digestive tract.


During this week's podcast, Dr. Ian Larson provides additional details on how the nanoparticle his research team developed actually functions. Dr. Larson talks about the broad practical applications of nanoparticle technology in the food industry and how other types of molecules or drugs might be administered via the nano particle delivery route. Dr. Larson also describes his work on drug delivery systems involving inhalation medication as well as liquid crystalline injections.
Dr.Ian Larson is a Senior Lecturer in Pharmaceutics and Formulation Science at Monash University in Australia.

Add a comment

  • Add a comment

  • Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?